Merrill Lynch Downgrades Janus Capital (JNS) to Neutral
- Wall Street turns defensive on Trump's protectionist stance
- Aetna's (AET) Humana (HUM) Takeover Blocked by Judge as Anticompetative
- Trump signs order withdrawing U.S. from Trans-Pacific trade deal
- Qualcomm (QCOM) Thrashed as Apple (AAPL) Lawsuit Threatens Licensing Business Model
- McDonald's (MCD) Tops Q4 EPS by 3c
Merrill Lynch Downgrades Janus Capital (NYSE: JNS) from Buy to Neutral.
You May Also Be Interested In
- UPDATE: Instinet Downgrades Qualcomm (QCOM) to Neutral
- Standpoint Research Downgrades Mercer International (MERC) to Hold
- Morgan Stanley Downgrades Workiva (WK) to Equalweight, Says Owning The Stock Could be Challenging In 2017
Create E-mail Alert Related CategoriesDowngrades
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!